Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV)
Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar
COPD in 2017 Hard enough before Now, new drugs and New phenotypes!
Resúmene... - Grupo Peruano de Salud Respiratoria - Neumología | Facebook
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. - Abstract - Europe PMC
The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. - Abstract - Europe PMC
3 Asthma and COPD Management | PPT
Association between inhaler use and risk of haemoptysis in patients with non‐cystic fibrosis bronchiectasis - Jang - 2015 - Respirology - Wiley Online Library
The Acute Management of Asthma | Clinical Reviews in Allergy & Immunology
A new alphabet for COPD care | European Respiratory Society